why choose us

First received: April 05, 2026

Clinical Trial: Selpercatinib and Body Composition

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Thyroid Cancer

Study Type: OBSERVATIONAL


Official Title: Selpercatinib and Body Composition

Brief Summary: investigation of body composition

Read more